Thomas Schroeter
Scripps Research Institute
11 Papers
188 Citations
Thomas Schroeter is an academic researcher from Scripps Research Institute. The author has contributed to research in topics: Rho-associated protein kinase & Proto-oncogene tyrosine-protein kinase Src. The author has an hindex of 8, co-authored 11 publications.
Chat about Author
Papers
Isoform and Splice-Variant Specific Functions of Dynamin-2 Revealed by Analysis of Conditional Knock-Out Cells
TL;DR: Surprisingly, CME and p75 exocytosis were efficiently rescued by reintroduction of Dyn2, but not Dyn1, suggesting that these two isoforms function differentially in vesicular trafficking in nonneuronal cells.
Patent
Bicyclic heteroaryls as kinase inhibitors
Yangbo Feng,Yen Ting Chen,Hampton Sessions,Jitendra Kumar Mishra,Sarwat Chowdhury,Yan Yin,Philip LoGrasso,Jun-Li Luo,Thomas D. Bannister,Thomas Schroeter +9 more
- 22 Oct 2010
TL;DR: In this article, a heteroaryl compound having inhibitory bioactivity with respect to a Rho kinase, an AKT kinase or a p70S6K kinase was presented.
85
Patent
Benzimidazoles and analogs as rho kinase inhibitors
Yangbo Feng,Philip LoGrasso,Thomas D. Bannister,Thomas Schroeter,Hampton Sessions,Lei Yao,Bo Wang,Michael P. Smolinski,Yen Ting Chen,Yan Yin,Bozena Frackowiak-Wojtasek,Sarwat Chowdhury +11 more
- 18 Dec 2008
TL;DR: In this article, a list of compounds useful as Rho kinase inhibitors according to formula IA or IB is presented, wherein A, B, D, E, R1, R2 and Ar1 are as defined herein, and any tautomer, salt, stereoisomer, hydrate, solvent or prodrug thereof, pharmaceutical compositions, methods of treatment, and synthetic methods are provided.
28
Patent
Quinazoline derivatives as kinase inhibitors
Yangbo Feng,Philip LoGrasso,Thomas D. Bannister,Thomas Schroeter,Xingang Fang,Yan Yin,Yen Ting Chen,Hampton Sessions,Sarwat Chowdhury,Jun-Li Luo,Tomas Vojkovsky +10 more
- 11 Nov 2009
TL;DR: In this article, quinazoline compounds that can inhibit the bioactivity of one or more kinase enzymes, including a Rho kinase, an AKT kinase or a p70S6K kinase were described.
21
Patent
Urea and carbamate compounds and analogs as kinase inhibitors
Yangbo Feng,Philip LoGrasso,Thomas Schroeter,Yan Yin +3 more
- 17 Sep 2009
TL;DR: In this paper, the authors describe compounds that can inhibit the bioactivity of one or more kinases such as any of Rho kinases, PKB (Akt), p70S6K, LIM kinases or IKK kinases.
20